Abbott’s Libre Duo gets CE mark in first major move on ketone monitoring
Abbott has secured CE mark approval for Libre Duo, its new dual glucose-ketone sensor designed for people with diabetes. The launch could...
Stories, guides and sensor tips
LIBRE LIFE LATEST NEWS
Articles
-
-
Dexcom G8 CGM: release timeline, expectations and what comes next
Dexcom’s Investor Day gave the clearest public preview yet of G8 CGM. From launch timing and 15-day wear to a smaller sensor...
-
Insulet raises 2026 outlook as Omnipod growth continues
Insulet has upgraded its 2026 revenue forecast after a strong start to the year, driven by global demand for Omnipod systems. Alongside growth,...
-
Omnipod 5 Recall: Insulet Reports 18 Adverse Events Linked to Insulin Delivery
Insulet recalls small proportion of its Omnipod 5 insulin patch pump pods after identifying a manufacturing issue that could lead to under-delivery...
-
NHS Libre 3 Phase-Out, Abbott Court Ruling and Global Updates
FreeStyle Libre news in March 2026 centres on a key change for UK prescriptions and several international developments.
-
Tandem Diabetes Care expands Mobi to Android while Europe still pending
Tandem Mobi insulin pump launches on Android in the US but despite CE mark has yet to be available in Europe.
-
CamDiab moves towards fully closed-loop insulin delivery
CamDiab’s automated insulin delivery technology gets regulatory progress toward fully closed-loop system.
-
Global survey highlights need for predictive glucose technology
A global survey by Roche of more than 4,300 people with diabetes has highlighted the daily planning, uncertainty and mental effort involved...
-
Portal Diabetes receives FDA designation for implantable insulin pump
News from Portal Diabetes that new medtech for an implantable insulin pump has reached an early regulatory milestone in the US.
-
Eversense 365 plans European rollout
After gaining a CE mark in January, the rollout of Eversense 365 implantable sensor, designed to last for a full year is...
-
Medtronic Diabetes becomes MiniMed
Medtronic officially spins off diabetes business to become standalone company MiniMed. Includes news of regulatory updates for the MiniMed insulin pump system.
-
Dexcom looks to expand CGM access as leadership changes take effect
An update on Dexcom's 2026 plans with changes in senior leadership and a push for wider access to CGM technology.
-
Beta Bionics faces regulatory scrutiny and insider share sales
Reporting on the latest from Beta Bionics following FDA warning letter and insider share sales.
